Zivo Bioscience Inc ZIVO
Trading Information
- Previous Close Price
- $6.15
- Day Range
- $6.25–6.25
- 52-Week Range
- $1.11–17.50
- Bid/Ask
- $6.24 / $7.25
- Shares Outstanding
- 4.22M
- Market Cap
- $24.30M
- Volume/Avg
- 100 / 1,430
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 109.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 7
- Website
- https://www.zivobioscience.com
Valuation
|
Metric
|
ZIVO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 109.76 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ZIVO
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.08 |
Interest Coverage | −305.54 |
Quick Ratio
ZIVO
Profitability
|
Metric
|
ZIVO
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ZIVO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|$<v!T%^ | LOCK|XZFH | $136B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!<lLr#$ | LOCK|z!D^% | $84B | |||
| Moderna Inc
MRNA
| LOCK|!TC@Qmb | LOCK|yRl | $81B | |||
| argenx SE ADR
ARGX
| LOCK|z^n!>#@ | LOCK|@!# | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|TNm!L% | LOCK|Vb | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|@?Cc>x | LOCK|XPw< | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^@tq$pd | LOCK|^!$T | $28B | |||
| Incyte Corp
INCY
| LOCK|S#?&f? | LOCK|qr$ | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|W?jX!&T | LOCK|jDT | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|<@^G>t | LOCK|SX! | $14B |
United States